S-Equol mitigates motivational deficits and dysregulation associated with HIV-1
Abstract Motivational deficits (e.g., apathy) and dysregulation (e.g., addiction) in HIV-1 seropositive individuals, despite treatment with combination antiretroviral therapy, necessitates the development of innovative adjunctive therapeutics. S-Equol (SE), a selective estrogen receptor β agonist, h...
Guardado en:
Autores principales: | Kristen A. McLaurin, Sarah J. Bertrand, Jessica M. Illenberger, Steven B. Harrod, Charles F. Mactutus, Rosemarie M. Booze |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e54c76ad5c684d5f8c80d1bf6cbe203a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Neurodevelopmental Processes in the Prefrontal Cortex Derailed by Chronic HIV-1 Viral Protein Exposure
por: Kristen A. McLaurin, et al.
Publicado: (2021) -
Association between Equol Production Status and Nonalcoholic Steatohepatitis
por: Takemi Akahane, et al.
Publicado: (2021) -
Urinary equol levels are positively associated with urinary estradiol excretion in women
por: Tomoko Fujitani, et al.
Publicado: (2021) -
Motivating actions to mitigate plastic pollution
por: Lili Jia, et al.
Publicado: (2019) -
Potential Protective Effects of Equol (Soy Isoflavone Metabolite) on Coronary Heart Diseases—From Molecular Mechanisms to Studies in Humans
por: Xiao Zhang, et al.
Publicado: (2021)